BHC Bausch Health Companies Inc. Stock Quote

BHC [NYSE]

Healthcare | Drug Manufacturers - Specialty & Generic | Canada

Index	-	P/E	49.15	EPS (ttm)	0.12	Insider Own	2.30%	Shs Outstand	362.20M	Perf Week	-7.26%
Market Cap	2.15B	Forward P/E	1.38	EPS next Y	4.17	Insider Trans	-0.34%	Shs Float	345.70M	Perf Month	-37.36%
Income	43.00M	PEG	5.65	EPS next Q	0.99	Inst Own	66.80%	Short Float	4.72%	Perf Quarter	-42.21%
Sales	8.19B	P/S	0.26	EPS this Y	-67.40%	Inst Trans	18.58%	Short Ratio	2.16	Perf Half Y	-77.42%
Book/sh	-1.91	P/B	-	EPS next Y	20.03%	ROA	0.10%	Target Price	-	Perf Year	-79.60%
Cash/sh	1.77	P/C	3.26	EPS next 5Y	8.70%	ROE	-14.10%	52W Range	4.00 - 29.59	Perf YTD	-79.17%
Dividend	-	P/FCF	5.25	EPS past 5Y	17.60%	ROI	2.10%	52W High	-80.57%	Beta	1.35
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	-2.70%	Gross Margin	71.50%	52W Low	43.75%	ATR	0.61
Employees	19600	Current Ratio	1.10	Sales Q/Q	-6.30%	Oper. Margin	18.20%	RSI (14)	40.67	Volatility	6.36% 13.99%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	75.80%	Profit Margin	0.50%	Rel Volume	0.53	Prev Close	5.94
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 09 BMO	Payout	0.00%	Avg Volume	7.56M	Price	5.75
Recom	2.20	SMA20	-8.98%	SMA50	-23.80%	SMA200	-69.28%	Volume	4,013,338	Change	-3.20%

Jul-29-22

Downgrade

Truist

Buy → Hold

Jul-29-22

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$12 → $5

Jul-28-22

Downgrade

JP Morgan

Overweight → Neutral

Jun-13-22

Resumed

JP Morgan

Overweight

$12

Mar-24-21

Downgrade

BofA Securities

Neutral → Underperform

$27

Feb-17-21

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

$26 → $42

Jan-22-21

Downgrade

Piper Sandler

Overweight → Neutral

$25 → $30

Sep-17-20

Upgrade

BofA Securities

Underperform → Neutral

$19

Aug-24-20

Reiterated

H.C. Wainwright

Buy

$64 → $50

Aug-24-20

Reiterated

H.C. Wainwright

Buy

$50 → $64

Jun-17-20

Reiterated

H.C. Wainwright

Buy

$50 → $64

Apr-24-20

Initiated

Citigroup

Buy

$30

Apr-02-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Jan-29-20

Downgrade

Wolfe Research

Outperform → Peer Perform

Jan-22-20

Upgrade

Wells Fargo

Underweight → Equal Weight

$32

Dec-12-19

Upgrade

JP Morgan

Neutral → Overweight

$32 → $38

Dec-02-19

Initiated

Goldman

Neutral

Oct-25-19

Initiated

Cowen

Outperform

$35

Sep-12-19

Initiated

Guggenheim

Buy

Aug-15-19

Upgrade

TD Securities

Hold → Buy

Aug-15-22 10:05AM	Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision Zacks
Aug-12-22 06:10AM	7 Stock Price Predictions That Are Actually Worth Listening To InvestorPlace
Aug-10-22 06:00PM	Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit PR Newswire +9.07%
06:00PM	Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit CNW Group
11:56AM	Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down Zacks
07:00AM	Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) PR Newswire
07:00AM	Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) CNW Group
Aug-09-22 04:42PM	Why Bausch Health Stock Tumbled More Than 11% on Tuesday Motley Fool -11.30%
09:19AM	Bausch Health Stock Sinks on Earnings Miss and Lowered Guidance Barrons.com
08:35AM	Bausch Health (BHC) Q2 Earnings and Revenues Miss Estimates Zacks
08:22AM	Bausch Health Stock Sinks on Earnings Miss and Lowered Guidance Barrons.com
07:25AM	Bausch's stock slides 11.8% after announcing Q2 results MarketWatch
07:00AM	BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS PR Newswire
07:00AM	BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS CNW Group
Aug-08-22 09:14AM	Drug, Biotech Stocks' Q2 Earnings on Aug 9: EXEL, BHC & More Zacks
Aug-04-22 05:25PM	Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates Zacks
03:00PM	Bausch + Lomb Corporation (BLCO) Q2 2022 Earnings Call Transcript Motley Fool
07:36AM	Bausch + Lomb beats earnings and revenue expectations; stock is up 3% MarketWatch
Aug-03-22 05:35PM	Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates Zacks +13.54%
Aug-02-22 12:14PM	What's in the Cards for Bausch Health (BHC) Q2 Earnings? Zacks
10:00AM	Analysts Estimate Bausch Health (BHC) to Report a Decline in Earnings: What to Look Out for Zacks
Aug-01-22 06:15PM	Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know Zacks
11:06AM	Shareholders in Bausch Health Companies (NYSE:BHC) have lost 84%, as stock drops 47% this past week Simply Wall St.
Jul-29-22 01:57PM	BHC Stock Continues to Fall as Bausch Health Responds to Court Decision InvestorPlace -9.41%
01:44PM	Bausch Receives a Mortal Blow GuruFocus.com
10:34AM	Bausch Health stock tumbles toward lowest close since 1995 after confirming disappointing court ruling MarketWatch
09:35AM	Bausch (BHC) Loses 39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks
Jul-28-22 04:50PM	CANADA STOCKS-TSX notches 6-week high as investors position for rebound Reuters -41.24%
03:56PM	Why Shares of Bausch Health Companies Dropped 54.4% This Week Motley Fool
03:47PM	Bausch Health Stock Halted After Patent Ruling. The Decision Could Be the Worst Possible Outcome, Analyst Says. Barrons.com
03:45PM	Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation PR Newswire
02:34PM	Bausch Health stock plummets toward 27-year low after Bloomberg report of unfavorable court ruling MarketWatch
10:51AM	IIROC Trading Halt - BHC CNW Group
10:33AM	IIROC Trade Resumption - BHC CNW Group
10:30AM	IIROC Trading Halt - BHC CNW Group
10:18AM	IIROC Trading Halt - BHC CNW Group
10:12AM	IIROC Trading Halt - BHC CNW Group
10:12AM	IIROC Trade Resumption - BHC CNW Group
10:03AM	IIROC Trade Resumption - BHC CNW Group
09:29AM	Midday Movers: Meta Platforms, Bausch Health, Spirit Airlines and More Investing.com
09:04AM	10 Stocks to Buy According to Francis Chous Chou Associates Management Insider Monkey
Jul-27-22 07:00PM	Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9 CNW Group
Jul-26-22 03:45PM	'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst Benzinga
Jul-20-22 07:00AM	Bausch + Lomb Provides Leadership Update PR Newswire
07:00AM	Bausch + Lomb Provides Leadership Update CNW Group
Jul-13-22 07:00AM	Salix Announces 2022 Gastrointestinal Health Scholars Program Winners PR Newswire
Jul-11-22 09:17AM	10 Best Stocks to Buy for Long Term According to ValueAct Capital Insider Monkey
Jul-06-22 09:14AM	10 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins Insider Monkey -5.19%
Jul-02-22 10:30AM	Bausch Health Companies Inc. (NYSE:BHC) insiders placed bullish bets worth US$1.8m in the last 12 months Simply Wall St.
Jul-01-22 09:20AM	10 Best Stocks to Buy Now According to Billionaire Larry Robbins Insider Monkey
Jun-24-22 09:22PM	The IPO Market Has Gone Cold. Getting It Going Again Is likely to Take Some Time. Barrons.com +20.36%
01:37PM	Why Bausch Health Stock Is Bolting Higher Today Motley Fool
09:47AM	Bausch Health Names Hedge Fund Billionaire Paulson Chairman Bloomberg
09:21AM	Midday Movers: Carnival, Zendesk, Bausch Health and More Investing.com
06:23AM	Bausch Health's Joe Papa resigns from board, John Paulson named chairperson MarketWatch
Jun-23-22 04:54PM	Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors CNW Group
Jun-21-22 07:00AM	Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation PR Newswire
07:00AM	Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation CNW Group
Jun-20-22 07:00AM	Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress 2022 CNW Group
03:00AM	Failure to Launch: IPOs Are on Hold Until Markets Stabilize Barrons.com
Jun-19-22 04:52PM	Bausch Health: Mispriced Opportunity GuruFocus.com
Jun-17-22 09:36AM	Bausch (BHC) Suspends IPO Plans for Solta Medical Zacks
08:22AM	Bausch Health halts IPO plan for skin-care division, citing challenging market conditions MarketWatch
05:09AM	Bausch Health Shelves Its Plan for Solta IPO Amid Market Turmoil Barrons.com
Jun-16-22 07:59PM	Bausch Health Suspends Plan for IPO of Solta Skin-Care Unit Bloomberg -7.14%
05:48PM	UPDATE 2-Bausch Health suspends plans for Solta IPO Reuters
05:30PM	Bausch Health Provides Update on Solta Medical CNW Group
Jun-15-22 09:42AM	J.P. Morgan Makes 2 Bottom-Fishing Bets for Long-Term Gains TipRanks +5.95%
Jun-10-22 04:13PM	2 Cheap Stocks Trading at Deal of the Century Prices InvestorPlace
Jun-09-22 11:30AM	Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report? Zacks -6.89%
Jun-08-22 07:17AM	Bausch + Lomb tops profit expectations but revenue comes up shy MarketWatch
Jun-06-22 08:48AM	Implied Volatility Surging for Bausch (BHC) Stock Options Zacks
Jun-02-22 05:00PM	3 Value Stocks That Could 2x in a Recession InvestorPlace
08:57AM	Carl Icahns 2022 Portfolio: 9 Value Stock Picks Insider Monkey
Jun-01-22 05:21PM	10 Best Stocks to Buy According to Billionaire Carl Icahn Insider Monkey
May-19-22 06:59AM	New Strong Sell Stocks for May 19th Zacks
May-18-22 07:00AM	Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 CNW Group -9.79%
May-12-22 08:21PM	ProFracs Oil Services Below-Range IPO Shows Market Still Idling Bloomberg
May-11-22 07:00AM	Bausch Health Announces Participation In Upcoming Investor Conferences CNW Group +7.77%
May-10-22 04:05PM	Bausch Health Crashes On Unexpected Loss As Bausch & Lomb Starts Trading Investor's Business Daily -27.13%
03:39PM	Elon Musk willing to reverse Trumps Twitter ban, Netflix may include ads, Bausch Health slumps Yahoo Finance Video
02:01PM	Bausch Health Stock Sinks as Revenue Guidance Misses Forecasts Barrons.com
12:46PM	Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions CNW Group
12:11PM	Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook Benzinga
11:37AM	Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down Zacks
08:13AM	Bausch Health's stock falls 32% on revenue and earnings miss in Q1 MarketWatch
06:59AM	Bausch Health Companies Inc. Announces First-Quarter 2022 Results PR Newswire
May-09-22 03:32PM	RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow Benzinga -19.58%
May-07-22 12:00AM	Tougher IPO conditions mean companies have to switch tack Financial Times
May-06-22 04:56PM	Bausch + Lomb, Years Second-Biggest IPO, Pops in Public Debut Barrons.com
04:29PM	Bausch + Lomb Up in Debut After Below-Range $630 Million IPO Bloomberg
01:28PM	Bausch & Lomb climbs in debut after downsized listing Financial Times
01:05PM	Bausch + Lomb, PepGen Open for Trading. Heres How They Did. Barrons.com
12:52PM	Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut Reuters
12:09PM	UPDATE 2-Bausch + Lomb valued at $6.5 bln after stock ticks up in NYSE debut Reuters
12:08PM	Bausch Health Announces Thomas J. Appio As Chief Executive Officer CNW Group
12:07PM	Bausch + Lomb stock opens with a slight gain, to value the company at about $6.5 billion MarketWatch
07:03AM	The Famous Fed Put Is Now a Fed Call, and the Bad News Is Piling Up Barrons.com
06:38AM	Bausch + Lomb IPO prices below range after carnage in stock market MarketWatch
May-05-22 09:25PM	Bausch + Lomb Misses Target With IPO Raising $630 Million Bloomberg -7.40%

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bausch Health Companies Inc.	10% Owner	Jun 01	Sale	17.05	4,550,357	77,606,339	310,449,643	Jun 02 04:05 PM
Bausch Health Companies Inc.	10% Owner	May 10	Sale	17.05	35,000,000	596,925,000	315,000,000	May 12 04:18 PM
Spurr Robert	U.S. President-Pharma Business	Apr 14	Sale	22.19	1,595	35,393	90,506	Apr 15 04:32 PM
Spurr Robert	U.S. President-Pharma Business	Mar 15	Sale	22.20	4,846	107,581	92,101	Mar 16 04:39 PM
Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Mar 08	Sale	21.76	3,889	84,625	93,139	Mar 10 04:03 PM
Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Mar 02	Sale	23.37	11,077	258,869	101,102	Mar 04 04:58 PM
Spurr Robert	U.S. President-Pharma Business	Mar 02	Sale	23.37	1,595	37,275	65,394	Mar 04 04:09 PM
Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Mar 01	Sale	23.82	6,338	150,971	112,179	Mar 02 09:29 PM
Spurr Robert	U.S. President-Pharma Business	Feb 15	Sale	25.02	3,251	81,340	60,299	Feb 17 04:36 PM
Spurr Robert	U.S. President-Pharma Business	Jan 18	Sale	26.63	3,251	86,574	63,550	Jan 20 07:55 PM
Miller Steven D	Director	Nov 30	Buy	24.17	10,000	241,699	10,000	Dec 02 07:15 PM
Miller Steven D	Director	Nov 30	Buy	24.24	50,000	1,211,825	60,780	Dec 02 07:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience